Publication not explained
This publication has not yet been explained in plain language by the author(s). However, you can still read the publication.
If you are one of the authors, claim this publication so you can create a plain language summary to help more people find, understand and use it.
Featured Image
Read the Original
This page is a summary of: ¿Está justificada la inclusión de levofloxacino en el tratamiento antibiótico empírico de las exacerbaciones de la enfermedad pulmonar obstructiva crónica leve, en pacientes sin comorbilidad y menores de 65 años?, Archivos de Bronconeumología, January 2002, Elsevier,
DOI: 10.1016/s0300-2896(02)75286-1.
You can read the full text:
Contributors
The following have contributed to this page
